ACCEL Lite: Cardiovascular Safety of Testosterone-Replacement Therapy

Testosterone is widely prescribed to aging men but there have been concerns about heart-related safety. The FDA mandated that the makers of testosterone products conduct a trial to determine if these drugs increase the risk of heart attack or stroke.

In this interview, Steven E. Nissen, MD, MACC, and William E. Boden MD, FACC, discuss Cardiovascular Safety of Testosterone-Replacement Therapy

Related References:

  1. Lincoff AM, Bhasin S, Flevaris P, Mitchell LM, Basaria S, Boden WE, Cunningham GR, Granger CB, Khera M, Thompson IM Jr, Wang Q, Wolski K, Davey D, Kalahasti V, Khan N, Miller MG, Snabes MC, Chan A, Dubcenco E, Li X, Yi T, Huang B, Pencina KM, Travison TG, Nissen SE; TRAVERSE Study Investigators. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023 Jul 13;389(2):107-117. doi: 10.1056/NEJMoa2215025. Epub 2023 Jun 16. PMID: 37326322.

Clinical Topics: Acute Coronary Syndromes, Arrhythmias and Clinical EP, Heart Failure and Cardiomyopathies, Prevention, Pulmonary Hypertension and Venous Thromboembolism

Keywords: ACCELLite, Testosterone

< Back to Listings